Topical corticosteroids in inflammatory bowel disease. 1989

C J Mulder, and A A Rondas, and E H Wiltink, and G N Tytgat
Department of Hepato-Gastroenterology and Pharmacy, Academic Medical Centre, Amsterdam.

UI MeSH Term Description Entries
D003093 Colitis, Ulcerative Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN. Colitis Gravis,Idiopathic Proctocolitis,Inflammatory Bowel Disease, Ulcerative Colitis Type,Ulcerative Colitis
D004733 Enema Insertion of a solution or compound through the RECTUM with the purpose of cleansing the COLON or for diagnostic procedures. Enemata,Enemas,Enematas
D005938 Glucocorticoids A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. Glucocorticoid,Glucocorticoid Effect,Glucorticoid Effects,Effect, Glucocorticoid,Effects, Glucorticoid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents

Related Publications

C J Mulder, and A A Rondas, and E H Wiltink, and G N Tytgat
April 1993, Alimentary pharmacology & therapeutics,
C J Mulder, and A A Rondas, and E H Wiltink, and G N Tytgat
April 2003, Gut,
C J Mulder, and A A Rondas, and E H Wiltink, and G N Tytgat
January 2012, Digestion,
C J Mulder, and A A Rondas, and E H Wiltink, and G N Tytgat
October 1987, Journal of clinical gastroenterology,
C J Mulder, and A A Rondas, and E H Wiltink, and G N Tytgat
June 2004, Gastroenterology clinics of North America,
C J Mulder, and A A Rondas, and E H Wiltink, and G N Tytgat
December 2021, Nature reviews. Gastroenterology & hepatology,
C J Mulder, and A A Rondas, and E H Wiltink, and G N Tytgat
June 1995, Alimentary pharmacology & therapeutics,
C J Mulder, and A A Rondas, and E H Wiltink, and G N Tytgat
October 2021, Journal of Crohn's & colitis,
C J Mulder, and A A Rondas, and E H Wiltink, and G N Tytgat
July 2012, Current drug delivery,
C J Mulder, and A A Rondas, and E H Wiltink, and G N Tytgat
October 1995, Clinical nutrition (Edinburgh, Scotland),
Copied contents to your clipboard!